entertainment -WSS

entertainment

author：entertainment 2025-09-06 03:32:56 - browse：813

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： How generative AI is inspiring dreams of a health data revolution

WSS

The pain doctors face in trying to build their families

A new House health package & hospitals’ new site

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

New definition of a human embryo proposed amid rapid advances

Covid hospitalizations on the rise, Humana says

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

focus

entertainment

entertainment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Supreme Court strikes down use of affirmative action

Illumina names Agilent executive as new CEO

As demand for Covid shots wanes, Moderna seeks its next success

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Trump demands the U.S. pay no more for drugs than other countries … again

ALS advocates say criticism of new drugs misses bigger picture

New air purifier tech could be key to improving indoor air quality

Cancer drug shortages' outsize impact on ovarian cancer patients

focus

Hilary expected to bring catastrophic, life

What drug price negotiations mean for Medicare Part D

Living with Hashimoto's and celiac disease, and med school, too

FDA approves first treatment for ultra

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Advances in CAR

Wikipedia

leisure time

hotspot

entertainment